Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The APIT Study: Prospective Observational Study of the Incidence of Anti-platelet Factor 4 Antibodies in Suspected Immune-associated Arterial and/or Venous Thrombosis

NCT06650826 is registered in ClinicalTrials.gov with Cardioangiologisches Centrum Bethanien as lead sponsor.

NCT NCT06650826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06650826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The APIT Study: Prospective Observational Study of the Incidence of Anti-platelet Factor 4 Antibodies in Suspected Immune-associated Arterial and/or Venous Thrombosis
Lead sponsor
Cardioangiologisches Centrum Bethanien
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2024
Completion date
January 31, 2027
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arterial or venous thrombosis